Exousia Bio, Inc. (LMMY): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-05-31, while the company's latest annual report covers the year ended 2025-05-31. Its later filings do not report this line under the concept TickerFacts maps.

$7.9K
As of 2023-05-31
$10.1K2022-05-31: $10.1K2023-05-31: $7.9K$7.9K
2022-05-31 Cash & Equivalents (USD) 2023-05-31
Period endedCash & EquivalentsChange YoYSource filing
2023-05-31$7.9K-22.3%2023-09-01, Balance as of period end
2022-05-31$10.1Kn/a2023-09-01, Balance as of period end